Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108101842B reveals a one-pot synthesis for 2-hydroxy-4-carboxyquinoline, offering high purity, solvent recovery, and significant cost reduction in pharmaceutical manufacturing.
Patent CN111100101A reveals a low-cost mercury-catalyzed route for 3-benzofuranone compounds, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113943218B reveals molecular sieve catalyst method for p-phenyl acetophenone. Reduces waste and cost for agrochemical intermediate supply chains globally.
Advanced synthesis of (E)-2,4,5-trimethoxy-1-propenylbenzene via novel propionylation and dehydration. High purity >99%, low cost, scalable process for pharmaceutical intermediates.
Patent CN1561333A details alpha-haloenamine reagents for efficient polyamide synthesis. Discover cost-effective, high-purity intermediates for DNA-binding applications.
Patent CN108658871B details a continuous flow method for 4, 6-dichloro-5-methoxypyrimidine, offering high purity and reduced costs for API manufacturing.
Patent CN107840828B reveals a high-yield one-step fluorination route for 2-chloro-5-trifluoromethylpyrazine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN115504870B enables high-purity 4-methoxy-2-naphthol production with improved yield and supply chain reliability for global pharmaceutical manufacturers.
Novel synthesis route for herbicide intermediate Flumioxazin precursor offering cost reduction and supply chain reliability for agrochemical manufacturing partners.
Patent CN101948389A reveals a high-yield route for Flumioxazin intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for this critical agrochemical building block.
Patent CN110105305A enables green synthesis of 1,2-benzothiazine derivatives using ionic liquids, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel hydrolysis route for 2-(trifluoromethyl)benzaldehyde offers high purity and industrial scalability for pharma intermediates.
Advanced indirect electrooxidation patent CN104805466B offers sustainable manufacturing for high-purity pharmaceutical intermediates with reduced waste.
Patent CN110143935B details a novel Ru-catalyzed route to 2,5-disubstituted furans under air. This method offers mild conditions and high regioselectivity for reliable pharmaceutical intermediate supply.
Novel melt crystallization patent CN119977839A enables high-purity 2,4-DCBN production with significant cost reduction and supply chain reliability for global buyers.
Novel Fe-catalyzed method for polysubstituted dihydropyrroles. Mild conditions, high purity, cost-effective manufacturing for pharma intermediates.
Patent CN107188874A reveals efficient Cu-catalyzed Michael addition. High ee, mild conditions for pharma intermediates.
Patent CN110483316B reveals a safe, in-situ ketene route for high-purity L-carnitine. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN1121706A reveals a non-halide route for substituted aromatic amines, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN1042530C reveals a novel phase-transfer catalyzed route for alkylsulfinylbenzamides enabling cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.